EMA Authorised: Efmody (hydrocortisone) — Immedica Netherlands B.V.

View source ↗

Summary

EMA authorised Efmody (hydrocortisone) by Immedica Netherlands B.V. for congenital adrenal hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Efmody (hydrocortisone)

Snippet

Status: Authorised. Therapeutic area: Adrenal Hyperplasia, Congenital. MAH: Immedica Netherlands B.V.. Decision date: 20/02/2026